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Maureen W Groer1, Angel A Luciano2, Larry J Dishaw3, Terri L Ashmeade2, Elizabeth Miller4 and Jack A Gilbert5,6,7*Abstract
The very low birth weight (VLBW) infant is at great risk for marked dysbiosis of the gut microbiome due to multiple
factors, including physiological immaturity and prenatal/postnatal influences that disrupt the development of a
normal gut flora. However, little is known about the developmental succession of the microbiota in preterm infants
as they grow and mature. This review provides a synthesis of our understanding of the normal development of the
infant gut microbiome and contrasts this with dysbiotic development in the VLBW infant. The role of human milk in
normal gut microbial development is emphasized, along with the role of the gut microbiome in immune
development and gastroenteric health. Current research provides evidence that the gut microbiome interacts
extensively with many physiological systems and metabolic processes in the developing infant. However, to the
best of our knowledge, there are currently no studies prospectively mapping the gut microbiome of VLBW infants
through early childhood. This knowledge gap must be filled to inform a healthcare system that can provide for the
growth, health, and development of VLBW infants. The paper concludes with speculation about how the VLBW
infants’ gut microbiome might function through host-microbe interactions to contribute to the sequelae of preterm
birth, including its influence on growth, development, and general health of the infant host.
Keywords: Preterm infants, VLBW, Gut microbiota, HealthReview
Background
The variability of human life is extraordinary, yet this is
not surprising considering the multitudinous influences
wrought upon us by genetics, culture, and the environ-
ment. Human-associated microbial life, which is also
highly diverse, is influenced by many of the same factors.
The fact that microbial life provides considerable feed-
back on nearly all aspects of human physiology has not
been widely appreciated. The rich diversity of microbial
life represents an ancient evolutionary process of bal-
ance and benefit between host immunity and microbial
growth [1]. The microbiota are so significant to health
that NIH launched the Human Microbiome Project in
2007 [2] and, along with a diverse array of funding sources
globally, continues to fund an extraordinary array of host-
microbe investigations. Microbial life is known to develop* Correspondence: gilbertjack@gmail.com
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unless otherwise stated.in biological and anatomical niches and to be influenced
by a host of ecological and genetic factors [3]. While mi-
crobes colonize every available surface in and on the body,
the gut microbiome is most widely studied and consists of
trillions of microbes and millions of functional genes, liv-
ing in cooperation with each other and with the host [2].
The normal gut microbiota is estimated to consist of
up to 100 trillion microorganisms, comprising between
500 to 3,000 species [4], and nearly 5 million unique
genes, which is 100 times more genes than the human
genome [5]. The human host requires this both benign
and beneficial microbiota for normal function, including
nutritional, developmental, defensive, and physiologic pro-
cesses, resulting ultimately in immune tolerance to food
and bacterial antigens, protection against pathogens, and
maturation of the gastrointestinal epithelium [6]. The
influence of the microbiome on host physiology and de-
velopment is often considered to be immediate, but
new evidence is emerging suggesting that changes in
the microbiome early in life may affect host physiology
across the life span (for an excellent synthesis of these
concepts, we suggest Missing Microbes by Martin J. Blasertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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shifts in the external factors that may influence the infant
gut microbiome, including diet [7], must be properly cata-
logued if we are to be able to develop translational prac-
tices. Recent discoveries regarding the native microbiome
in human milk indicate that this first food introduced into
the gastrointestinal tract could have profound influences
on how we modulate early gut microbiome development
and, hence, the trajectory towards a stable, ‘adult’ micro-
biome [7].
Infancy and the gut microbiota
Much of what is known about the infant microbiome
has been from research on term infants, and fewer stud-
ies have focused on the preterm and low birth weight in-
fants. Term and preterm infants were thought to be
born essentially sterile, but new evidence of bacterial
translocation in utero [8] and the presence of microbial
life in preterm infants’ meconium [9] may refute this.
Observed lipopolysaccharide (LPS) in the cord blood of
preterm infants provides evidence of this translocation
process [10]. While these findings are still controversial,
they point to a profound ignorance of the founding of
our microbiota. When born vaginally, infants are quickly
colonized by trillions of maternal vaginal, enteric, skin,
and milk microorganisms. The microbiota of neonatal
skin, oral mucosa, and nasopharyngeal aspirates of vagi-
nally delivered term infants are similar to their mother's
vaginal microbiota, while Caesarean section (C-section)
infants harbor bacterial communities similar to skin
microbiota [11]. Over a relatively short period of time,
the vaginally delivered newborn develops its first gut
microbiome, which is largely composed of maternal
vaginal and enteric organisms. Some data suggest that
C-section-delivered infants have lower gut microbial
richness and diversity at 4 months of age, compared to
vaginally delivered infants [12]. Subsequently, during
the first year of life in full-term infants, the gut is colo-
nized by sequential blooms of microbes comprising ap-
proximately 1014 cells per milliliter of intestinal contents.
Most are anaerobes in the distal small intestine and colon,
but facultative anaerobes and aerobes also colonize the
upper gastrointestinal tract. Because the lower gastrointes-
tinal tract lumen is anoxic, only anaerobes and facultative
bacteria are capable of surviving. The term infant’s gut
microbiome matures over the first 3 years of life before it
is recognizable as an adult microbiome [3,13].
The gut microbiota of the term infant has been ob-
served to influence multiple processes including the
differentiation of epithelium, cross talk within the gut-
associated lymphoid tissue (GALT), gastrointestinal tract
morphology, nutrition, and metabolism [14-18]. Human
milk provides many nutrients for bacterial growth (including
prebiotics such as human milk oligosaccharides(HMOs) [19]), and breast-fed infants have nearly twice
the abundance of intestinal bacterial cells, but less di-
versity, than their formula-feeding counterparts (21). In
term infants, the species of microbes that colonize the
early gut differ between those who are breast-fed com-
pared to formula-fed infants. HMOs are broken down
into short-chain fatty acids that promote the growth of
Bifidobacteria and Lactobacillus [20]. Formula-fed in-
fant feces contain higher numbers of Atopobium, lower
numbers of Bifidobacterium, and an increased relative
abundance of Bacteroides [21]. Interestingly, when
breast-fed babies receive mixed feeding of both human
milk and formula, the microbiota shifts to a community
structure that more closely resembles that found in
formula-fed infants, which is similar to when the in-
fants begin solid food [14]. This ‘formula/solid food’
microbiome is dominated by Enterococci and Entero-
bacteria, Bacteroides, Clostridia, and other anaerobic
Streptococci [14]. Preterm infants may differ in the re-
sponsiveness of the gut to prebiotics such as HMOs. In
one study, administration of supplemental HMOs to
the feedings in 12 preterm infants did not result in the
expected increase in Bifidobacteria [22]. Hence, ma-
nipulation of the preterm infant gut microbiome may
be challenging because of different influences in the
early lives of these infants compared to term infants. In
general, there is much less known about the influence of
human milk feeding on the gut microbiome of preterm in-
fants, which represents a significant research gap.
Within the first year of life, the intestine will be colo-
nized by approximately 1,000 different species [20].
While human milk contains complex nutrients, it also
harbors many immune components and a recently de-
scribed microbiome (103 to 104 colony-forming units of
select species per milliliter of human milk) [23]. This
symbiotic mix of probiotic and prebiotic components,
combined with other sources including the environment
and immune activation, acts to populate the early gut
with a microbiota. Milk from preterm mothers is differ-
ent in many ways from that produced by term mothers.
For example, preterm milk appears to have a different
mix of human milk oligosaccharides that could influence
microbial growth [24].
The early gut microbiome is believed to maintain a
state of regulated inflammation that is important in pro-
viding cross talk between microbes of the intestinal epi-
thelium [6] and the GALT [20]. The development of a
normal infant gut and the immune system requires
interaction between intestinal epithelial cells, lymphoid
tissue, and the burgeoning commensal microbiota. Apop-
totic stimuli, reactive oxygen synthesis, and Toll-like re-
ceptor (TLR) signaling are induced by commensal bacteria
to produce a state of controlled inflammation that helps
develop the innate immune defenses and promotes
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microbiota alters gut microanatomy and function. There
is increased expression of genes that promote epithelial
turnover and synthesis of mucus, as well as elevated peri-
stalsis, which decreases small intestinal colonization; fi-
nally, various antimicrobial compounds are secreted in the
mucus [27,28]. These interactions enable the infant gut to
quickly develop tolerance to food antigens and the com-
mensal microbiota. This provides a barrier against pene-
tration of pathogenic microbes into the mucosa and
submucosa.
After weaning, the gut microbiota becomes firmly
established leading to a lifelong signature [29], a process
that usually takes place by about 3 years of age [3]. How-
ever, the early microbiome is likely to determine the sig-
nature of the adult microbiome, based on the founder
effect, whereby the original colonizing microbiota are in-
strumental in the successional direction of the assem-
blage. As a result, the initial colonizing microbiota is
likely to be a critical determinant in the development of
certain pediatric diseases [30]. The early microbiota pro-
duces active metabolites such as folate, butyrate, and
acetate, which could epigenetically alter gut epithelium
and hepatic and immune cells, a type of developmental
programming which might later translate into risks for a
variety of human diseases, including obesity [31].
The very low birth weight (VLBW) infant gut microbiome
As shown above, the term infant gut microbiome has
been the primary focus of existing research. Therefore,
we highlight the need to refocus our research para-
digm to fully explain how preterm birth might inter-
rupt normal developmental pathways. VLBW infants
(birth weight below 1,500 g) develop a very different,
‘sparse’ microbiome than that described for the full-
term infant. This developmentally challenged micro-
biota is very low in anaerobes, with coagulase-negative
Staphylococci, Enterococci, Enterobacteriaceae, and yeasts
being common microbial species [27]. In addition, VLBW
infants may be fed cow’s-milk-based formula or human
milk fortifiers that can create an entirely different meta-
bolic environment in the gut and thus may favor very dif-
ferent microbial communities [32]. Exposure to many
prenatal and postnatal insults may shape the succession of
the preterm infant gut microbiome. These infants often
experience rapid vaginal or C-section deliveries reducing
exposure to maternal vaginal and enteric microbiota. In
addition, mothers threatening preterm delivery often ex-
perience prolonged hospitalization and are treated with
antibiotics that may alter their microbiota, as well as that
of the fetus. The infants can be exposed to many inflam-
matory factors in utero (prenatal maternal illness, infec-
tions such as bacterial vaginosis and chorioamnionitis,
smoking and physiological stress) and then postnatally(formula feeding, invasive procedures, antibiotics and
medications that alter gastroenteric pH) and extremely
different microbial sources as compared to full-term neo-
nates. Furthermore, the hospital environment is likely to
be vastly different than home in terms of resident mi-
crobes and microbial resistance. VLBW infants require
prolonged hospitalization and often develop a ‘neonatal
intensive care unit (NICU)’ flora [33]. The VLBW infant
gut is immature and fragile, and extended periods of fast-
ing and alterations in gastrointestinal motility and perfu-
sion may affect colonization and increase inflammation. It
is logical that the composition of the VLBW infant gut mi-
crobial community will influence the successional devel-
opment of the microbiota, and bacteria that established
early on will inhabit important niches later in life. VLBW
infants often display a delay in establishing an adult
microbiota, compared to full-term children [20]. These
delays and alterations in commensal colonization in early
life may preempt gastroenteral illnesses and shifts in im-
mune balance, leading to atopy and neurodevelopmental
effects in childhood and later life [20].
One recent longitudinal study of two VLBW infants
found that the gut microbiome was influenced by micro-
organisms in the NICU environment, and antibiotic-
resistant microbes were colonizing these infants’ guts
[33]. Genes conferring antibiotic resistance can transfer
among microbes, including pathogens, a process termed
the gut-associated resistome [34]. In another longitu-
dinal study of a single VLBW infant, born by C-section,
nine stool samples taken during the third week of life
showed a shift towards fermentation-based metabolism
(obligate anaerobes) which overtook Escherichia coli as
the most abundant microbial species [35]. A very recent
paper describes a study of microbial succession in 58
VLBW infants grouped into three gestational ages
(<26 weeks, 26–28 weeks, and >28 weeks) [36]. Fecal
samples (N = 922 specimens) were studied across these
infant groups as the infants grew and developed. The
results support a programmed and non-random devel-
opmental succession of microbiota, from Bacilli to
Gammaproteobacteria to Clostridia, with colonization
dominated by anaerobes by 33–36 weeks postconcep-
tual age (weeks of age at birth + weeks of age since
birth). There were frequent and abrupt unpredictable
shifts in the composition of microbial life along the
course of this trajectory. The pace of ecological succes-
sion, but not progression of taxonomic changes, was in-
fluenced by external factors such as breast milk
feeding, antibiotics, and mode of birth. This important
study will become even more valuable if the infants are
subject to follow-up investigation later in life, so that
the infant successional ecology and founder effect of
their microbiome may be linked to early childhood ill-
ness progression and health status.
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VLBW infant deaths contributed 35% to all infant deaths
in 2009 (http://www.cdc.gov/reproductivehealth/Mater-
nalInfantHealth/PretermBirth.htm). While most VLBW
infants survive, the costs of care and long-term seque-
lae are highly significant. VLBW infants are at risk of
hematological, cardiorespiratory, gastroenterologic, in-
fectious, and neurological disorders in their early lives
in the NICU (http://www.nlm.nih.gov/medlineplus/pre-
maturebabies.html). These, as well as prenatal and
birth-related insults, contribute to long-term morbidity.
VLBW infants are usually the product of preterm birth
(PTB), but some may be born closer to term (late pre-
term) and are small for gestational age. There are very
few prospective studies of the VLBW gut microbiome
over the NICU stay that assess more than a few VLBW
infants [33-36].
The dysbiosis of microbial succession in VLBW infants
is likely to increase the risk of infections and inflamma-
tory processes. Sepsis is a major threat to these infants
and may occur at any time during hospitalization. In a
recent study, sepsis-causing pathogens were isolated
from stools in 7 of 11 infants, and fecal and blood sam-
ples were provisionally matched. The organisms identi-
fied were not considered members of the normal
microbiota (group B Streptococcus, Serratia marcescens,
and invasive E. coli) [37]. Both late-onset sepsis and nec-
rotizing enterocolitis (NEC) were associated with micro-
biomes dominated by Proteobacteria and Firmicutes
[38]. NEC has an incidence of about 7% in the United
States, and up to 10% of VLBW infants developed it
[39,40]. Developmental immaturity in innate immune
function may occur in VLBW infants, which interrupts
the normal ability of enterocytes to control invasive
non-commensal bacteria and results in a proinflamma-
tory cascade [41]. Bacterial translocation across the epi-
thelial barrier is associated with excessive TLR-4 signaling
that produces the inflammation and necrosis characteris-
tic of this disease [42]. What follows is an excessive in-
flammatory response that predisposes to NEC [20,41]. Use
of human milk significantly reduces the risk for NEC and
sepsis in the NICU [43], perhaps in part because human
milk introduces a diversity of commensal microbial spe-
cies and decreases the proinflammatory cascade that leads
to NEC. Secretory immunoglobulin A (SIgA) in milk plays
a role in immune exclusion by limiting the ability of mi-
crobes to penetrate into the epithelium, regulating com-
mensal microbial growth, and affecting intestinal epithelial
gene expression [44,45].
Few studies have mapped normal, non-medically
treated full-term infants’ or VLBW infants’ microbiota
over time after discharge from the hospital. Eggesbo
et al. [46] describe the colonization process during the
first 4 months of life in 85 healthy term infants notreceiving medical interventions and demonstrated a devel-
opmental trajectory for the establishment of the adult-
type microbiome. Normal early infancy colonization
patterns showed less complexity and higher transient
levels of facultative anaerobes in infancy compared to
later in life [27]. The initial colonizers at 4 days of life
were Enterobacteriaceae, with Klebsiella and Enterobac-
ter, more common in neonatal gut compared to adults.
Bifidobacterium species were also prevalent, as was
Lactobacilli. Bifidobacterium is the dominant bacteria
in the guts of breast-fed infants. At 4 months of age,
dramatic differences in microbiota occurred, which likely
was due to changes in feeding.
The adult-type microbiome, established by 3 years of
age in healthy full-term newborns, is stable through
childhood and into old age [30]. It is unlikely, however,
that the same pattern and timing would occur in the
VLBW infant; yet, there do not appear to be studies in
the literature prospectively mapping the gut microbiome
of VLBW infants through early childhood. This is an im-
portant gap as the role of the microbiome in the growth,
health, and development of VLBW infants provides es-
sential data to aid doctors in their care.
VLBW infant growth and the gut microbiome
VLBW infants generally experience catch-up growth
during early childhood, with most of this growth occur-
ring in the first 2 years of life but continuing until 8 years
of age [47]. This period of rapid growth and weight gain
has been linked to later risk of coronary artery disease
and insulin resistance [48]. One aspect of growth that
may be related to the microbiome is the risk for later
obesity (and attendant disorders such as metabolic syn-
drome and type 2 diabetes), particularly in small for ges-
tational age infants. VLBW infants are often small for
gestational age as well as prematurely born and could be
more at risk for later obesity rather than underweight
[49]. In addition, a preterm infant can suffer postnatal
growth failure due to inadequate nutritional intake and
illness, so that by term, they are considered ‘small for
dates’. Known as the Barker or ‘thrifty phenotype’ hy-
pothesis [50], the relationship between prenatal nutri-
tional deprivation, either through maternal deprivation,
high-altitude pregnancy, or placental insufficiency, is hy-
pothesized to lead to a metabolic programming that ul-
timately increases the risk for later obesity in small for
gestational age infants. Thus, later obesity has a U-
shaped relationship with early nutrition, with low and
high weight at birth increasing the risk for these meta-
bolic alterations. General thinking has been that infants
who have developed a metabolic adaptation to reduced
prenatal nutrition are born with set points and mecha-
nisms geared towards metabolic efficiency. This adaptive
fetal phenotype may result in obesity when nutritional
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be enhanced in VLBW small for gestational age infants
due to the alterations described previously in the VLBW
infants’ gut microbiome. Some studies suggest that there
is an association between obesity development in VLBW
infants and the rate of accelerated catch-up growth
during infancy [49]. Another possibility is that normal
nutrient digestion and processing, metabolism, and
microbe-host signaling become disturbed in the VLBW
infant due to dysbiosis, and this could contribute to
obesity. More research is needed to explore this pos-
sible relationship over longer time spans.
The obesity-microbiome relationship has been the
subject of many studies. In a very large study of 74,946
children from 31 centers in 18 countries, antibiotic treat-
ment in the first 12 months of life was found to be asso-
ciated with current BMI in boys, ages 5–8, but not girls
[51]. In a study comparing obese to lean children, fecal
samples were analyzed to determine the concentrations
of bacterial species belonging to the following genera:
Bacteroides, Bifidobacterium, Clostridium, Staphylococcus,
and Lactobacillus [52]. There were significant differences
in the microbiomes of obese compared to lean children
(ages 6–16). The ratio of Firmicutes to Bacteroidetes was
higher in obese children, and low levels of Bacteroides vul-
gatus and high concentrations of Lactobacillus spp. and
Staphylococcus spp. were positively associated with energy
intake in both obese and lean children. A relationship be-
tween inflammation (plasma high-sensitivity C-reactive
protein [hsCRP]) and Lactobacillus spp. was observed in
the obese children in this study. Many obese individuals
(up to 50%), including children, develop insulin resistance
and metabolic syndrome. In an adult study, fecal trans-
plants from lean individuals to individuals with metabolic
syndrome reversed the insulin resistance, implicating the
microbiota in metabolic syndrome etiology [53]. Maternal
prenatal BMI may influence the infant microbiome and
later risk for obesity. The childhood obesity epidemic in
the United States may be due to many factors, including
diet and sedentary behaviors, but maternal influences may
be important and may operate through the maternal
prepregnancy and pregnancy BMI. Maternal obesity
was associated with higher levels of Bacteroides and
Prevotella, and these microorganisms appeared higher
in the children at 1 and 6 months of age [54], suggest-
ing intergenerational transfer of a microbiome that is
associated with obesity [55].
VLBW infant development and the gut microbiome
The VLBW infant is at risk for long-term disabilities,
with increased risks for neurological sequelae including
cognitive disabilities, blindness, cerebral palsy, and hear-
ing impairments compared to infants of later gestational
age [56]. The presence of attention deficit/hyperactivitydisorder is five times higher in VLBWs compared to
full-term infants [57]. In a 30-month follow-up of
VLBW infants with gestational ages of 25 weeks or less,
over half had developmental delays, neuromotor disabil-
ity, blindness, or hearing loss [58]. While there are cer-
tainly clear relationships between gestational age, birth
weight, and neurological impairment, the role of the
microbiome has barely been investigated. There is an
evolving literature, mostly with animal studies, showing
the effect of the gut microbiome on neurogenesis and
neuronal circuits involved in motor function, stress re-
sponses, and anxiety [59]. The gut-brain axis is both
complex and extensive, with the enteric nervous system
providing a mechanism for cross talk. Research has dem-
onstrated that the microbiota is involved in this communi-
cation pathway (the ‘brain-gut-enteric-microbiota axis’)
and may impact brain development and plasticity, as well
as gene transcription and behavioral responses [60]. In
adults, multiple studies have explored the relationship
between the gut microbiome and a diverse number of
neuropsychiatric illnesses: schizophrenia, mood disor-
ders, autism spectrum disorders (ASDs), anorexia ner-
vosa, Tourette syndrome, attention deficit hyperactivity
disorder, narcolepsy, posttraumatic stress disorder, and
chronic fatigue syndrome [61]. Anxiety also has been
linked to the microbiome in mice, and brain plasticity
has been speculated to be dependent on normal devel-
opment of the microbiome [59]. It may be that patho-
gens leak from the gut under certain circumstances and
the microbe-associated molecular patterns (MAMPs)
react with TLRs to produce inflammatory signals that
act on the brain. Another potential pathway may be
through autoimmune mechanisms. These pathways have
not been studied in VLBW neonate growth and develop-
ment. It is possible that soft neurological signs and devel-
opmental delays in these children may be associated with
microbial dysbiosis. One neurological relationship of ab-
normal infant microbial colonization is seen in ASD which
is approximately three times more likely to develop in
VLBW infants with gestational age <27 weeks compared
with infants born at term. Studies show that the shorter
the gestation, the greater the risk [62]. ASD has been con-
sistently associated with evidence of both neuroinflamma-
tion and abnormal gut flora such as abnormal Clostridia
species and skewed Firmicutes to Bacteroidetes ratios [63].
A relationship between gastrointestinal symptoms and aut-
ism severity has also been observed [64], pointing to a po-
tential relationship with the gut microbiota. Importantly,
several bacterial probiotic therapies have also been posited
and have shown high efficacy in mouse models [65].
VLBW infant health and the gut microbiome
The establishment of commensal microbiota influences
the infant’s immune system development. In fact, there
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actions in infancy compared to adulthood. The early life
gut responds very differently than the adult gut to
inflammogenic stimuli such as the proinflammatory
cytokine tumor necrosis factor-alpha (TNFα). The infant
gut microbiome coevolves with the developing gut; in
fact, the immature immune system and immune re-
sponses are primed by transient inflammatory signals
from microbe-gut interactions [20,66]. The development
of both the innate and acquired immune systems in in-
fants requires orchestrated interactions and controlled
inflammation within the developing gut. The intestinal
immune system is very extensive, with up to 60% of the
immune cells residing in the GALT [59]. Dendritic cells
(DCs) sample the commensal microbes that are present
in the gut lumen in a process that begins with recogni-
tion of the MAMPs by TLRs on intestinal epithelial cells
and penetrating DCs. The TLR activation results in se-
cretion of cytokines such as TSLP and TGF-β, both of
which promote tolerogenesis in DCs [20]. DCs produce
immunoregulatory cytokines such as IL-10 that results
in upregulation of T regulatory cells. In addition, DCs
transport bacteria to the mesenteric lymph nodes where
B cells recognize epitopes and become IgA-secreting
plasma cells specific to the microbes. This IgA is recir-
culated back to the lamina propria of the intestine,
where it binds with a secretory piece and enters the in-
testinal lumen to contain bacteria from penetrating the
epithelium [17]. By these mechanisms, the immune sys-
tem protects against specific bacteria and isolates them
to the gut. In the VLBW population, the enteric effects
of abnormal colonization can interfere with these nor-
mal processes. There are potential developmental differ-
ences in intestinal epithelial cell responses, leading to
decreased immunoregulation and increased inflamma-
tion, both of which may contribute to NEC. Another im-
portant mechanism is how the bacteria in the gut alter
the systemic immune system, and these interactions
offer explanation for the adverse health effects of inad-
equate or abnormal colonization. Depending on the mi-
crobial species, effects far distal to the gut can be
observed, such as systemic autoimmune diseases and al-
lergies, which appear to be influenced by immune bal-
ance orchestrated in the gut. If normal microbiota
development is somehow impacted, as is likely the case
for VLBW infants, there may be an increased risk for
later enteric diseases and defects in immune tolerance,
atopy, and asthma [20]. Immunological consequences of
the abnormal microbiota profile that may occur in
VLBW infants as they develop include disruption in the
Th1/Th2/Th17/Treg immune balance, which may, in part,
explain the relationship between inadequate colonization
in VLBW infants and later atopic disease and asthma.
Since VLBW infants are often born by C-section andhave exposure to antibiotics in early life, they have
additional risks. In a study of infants born by C-section
with atopic family history, the odds ratio for develop-
ment of asthma was 8 [67]. There is also a well-known
epidemiological association between antibiotic use and
later development of asthma, which often is explained
by low microbial exposure (the hygiene hypothesis)
[68,69]. Type I diabetes is an autoimmune-mediated meta-
bolic disorder potentially associated with the microbiome.
Newly diagnosed Mexican children with type I diabetes
had higher fecal Bacteroides and reduced Prevotella,
Megamonas, and Acidaminococcus compared to control
children. Diabetic children also had higher antibiotic ex-
posure than controls [70].
Enteric effects of the VLBW microbiome are not lim-
ited to the early postnatal period. Antibiotic exposure,
which is an extremely common intervention in VLBWs,
has been associated with increased later risk for Crohn’s
disease, with increasing risk related to frequency of
antibiotic exposure in children [71]. In another study,
C-section delivery and being small for gestational age
increased the risk of celiac disease [67]. Obviously,
these factors may or may not be associated with the
microbiome.
Conclusions
It is becoming increasingly clear that the early infant gut
microbiome is an important regulator of many develop-
ing physiologies. These interactions can influence risk
for a variety of pathophysiological effects into childhood
and even adult life. It is also apparent that infant feeding
is a critical determinant of the early gut microbiome,
and so, early feeding habits may have important long-
term effects. The VLBW infant is disadvantaged in many
ways, including the likely development of dysbiosis of
the gut microbiome. Exploration of the long-term effects
of this abnormal microbial number, diversity, and suc-
cession has not yet been done and is critically needed in
order to intervene both early and later in the lives of
these children.
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